These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35085385)

  • 1. Longitudinal Comparison of Automated SARS-CoV-2 Serology Assays in Assessing Virus Neutralization Capacity in COVID-19 Convalescent Sera.
    Niedrist T; Drexler C; Torreiter PP; Matejka J; Strahlhofer-Augsten M; Kral S; Riegler S; Gülly C; Zurl C; Kriegl L; Krause R; Berghold A; Steinmetz I; Schlenke P; Herrmann M
    Arch Pathol Lab Med; 2022 May; 146(5):538-546. PubMed ID: 35085385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020.
    Zhang S; Ma P; Orzechowski M; Lemmer A; Rzasa K; Bagnall J; Barkho S; Chen M; He L; Neitupski R; Tran V; Ackerman R; Gath E; Bond A; Frongillo G; Cleland T; Golas A; Gaca A; Fitzgerald M; Kelly K; Hazegh K; Dumont L; Hoffman C; Homer M; Marks P; Woolley A; Wong S; Gomez J; Livny J; Hung D
    mBio; 2023 Apr; 14(2):e0352322. PubMed ID: 36786604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum.
    Lu L; Chu AW; Zhang RR; Chan WM; Ip JD; Tsoi HW; Chen LL; Cai JP; Lung DC; Tam AR; Yau YS; Kwan MY; To WK; Tsang OT; Lee LL; Yi H; Ip TC; Poon RW; Siu GK; Mok BW; Cheng VC; Chan KH; Yuen KY; Hung IF; To KK
    EBioMedicine; 2021 Sep; 71():103544. PubMed ID: 34419925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers.
    Heaney CD; Pisanic N; Randad PR; Kruczynski K; Howard T; Zhu X; Littlefield K; Patel EU; Shrestha R; Laeyendecker O; Shoham S; Sullivan D; Gebo K; Hanley D; Redd AD; Quinn TC; Casadevall A; Zenilman JM; Pekosz A; Bloch EM; Tobian AAR
    J Clin Virol; 2021 Dec; 145():104997. PubMed ID: 34695724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference.
    Graninger M; Jani CM; Reuberger E; Prüger K; Gaspar P; Springer DN; Borsodi C; Weidner L; Rabady S; Puchhammer-Stöckl E; Jungbauer C; Höltl E; Aberle JH; Stiasny K; Weseslindtner L
    Microbiol Spectr; 2023 Feb; 11(1):e0231422. PubMed ID: 36622205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
    Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests.
    Rak A; Donina S; Zabrodskaya Y; Rudenko L; Isakova-Sivak I
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination.
    Srivastava K; West KA; De Giorgi V; Holbrook MR; Bovin NV; Henry SM; Flegel WA
    Microbiol Spectr; 2021 Dec; 9(3):e0083021. PubMed ID: 34878316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
    Benner SE; Patel EU; Laeyendecker O; Pekosz A; Littlefield K; Eby Y; Fernandez RE; Miller J; Kirby CS; Keruly M; Klock E; Baker OR; Schmidt HA; Shrestha R; Burgess I; Bonny TS; Clarke W; Caturegli P; Sullivan D; Shoham S; Quinn TC; Bloch EM; Casadevall A; Tobian AAR; Redd AD
    J Infect Dis; 2020 Nov; 222(12):1974-1984. PubMed ID: 32910175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-Ecuador.
    Villacrés-Granda B; Paz E; Burbano MJ; Villacrés-Granda I; Armijos D; Aguirre M
    J Med Virol; 2022 Sep; 94(9):4246-4252. PubMed ID: 35585654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotyping and quantitation of the humoral immune response to SARS-CoV-2.
    Goyins KA; Yu JJ; Papp SB; Beddard R; Murthy AK; Chambers JP; Arulanandam BP
    Exp Biol Med (Maywood); 2022 Jun; 247(12):1055-1060. PubMed ID: 35369776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant.
    Springer DN; Perkmann T; Jani CM; Mucher P; Prüger K; Marculescu R; Reuberger E; Camp JV; Graninger M; Borsodi C; Deutsch J; Lammel O; Aberle SW; Puchhammer-Stöckl E; Haslacher H; Höltl E; Aberle JH; Stiasny K; Weseslindtner L
    Microbiol Spectr; 2022 Oct; 10(5):e0212922. PubMed ID: 36005839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization.
    Salazar E; Kuchipudi SV; Christensen PA; Eagar T; Yi X; Zhao P; Jin Z; Long SW; Olsen RJ; Chen J; Castillo B; Leveque C; Towers D; Lavinder J; Gollihar J; Cardona J; Ippolito G; Nissly R; Bird I; Greenawalt D; Rossi RM; Gontu A; Srinivasan S; Poojary I; Cattadori IM; Hudson PJ; Josleyn NM; Prugar L; Huie K; Herbert A; Bernard DW; Dye JM; Kapur V; Musser JM
    J Clin Invest; 2020 Dec; 130(12):6728-6738. PubMed ID: 32910806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.
    Lamikanra A; Nguyen D; Simmonds P; Williams S; Bentley EM; Rowe C; Otter AD; Brooks T; Gilmour K; Mai A; Dadhra J; Csatari M; Ziyenge S; Oliveira M; Ploeg R; Tsang P; Zambon M; Gopal R; Xiao JH; Townsend A; Roberts D; Harvala H
    Transfusion; 2021 Oct; 61(10):2837-2843. PubMed ID: 34342366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.
    Theel ES; Johnson PW; Kunze KL; Wu L; Gorsh AP; Granger D; Roforth MM; Jerde CR; Lasho M; Andersen KJ; Murphy BM; Harring J; Lake DF; Svarovsky SA; Senefeld JW; Carter RE; Joyner MJ; Baumann NA; Mills JR
    J Clin Microbiol; 2021 Aug; 59(9):e0123121. PubMed ID: 34166066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
    DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
    J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.